Pay-IT-forward gonorrhea testing among men who have SEX with men: the pioneer pragmatic randomized controlled trial - most men who have SEX with men (MSM) do not receive gonorrhea testing,…

Active Project Grant Awarded Last action

Award ID
R01AI158826
Recipient
Awarding agency
Obligated
$8,652,904

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 94% complete
Originally
Funding
  • $8,014,069.00 Federal
  • $638,835.00 Non-federal
Place of performance
Chapel Hill, NC 27599, USA

Award details come from USAspending.gov.

Description

Pay-IT-forward gonorrhea testing among men who have SEX with men: the pioneer pragmatic randomized controlled trial - most men who have SEX with men (MSM) do not receive gonorrhea testing, contributing to delayed treatment and potentially amplifying antimicrobial resistance. Poor test uptake is often related to costs associated with STD testing and minimal community engagement. We have developed a pay-IT-forward intervention to enhance gonorrhea testing among MSM. Pay-IT-forward involves an individual receiving a gift (in this case, a gonorrhea test) and then be provided the opportunity to give a gift (in this case, money to support gonorrhea testing) to another person. Pay-IT-forward is an example of upstream reciprocity theory suggesting that people who are helped by someone feel a "warm glow" that makes them more likely to help others. Pay-IT-forward has been used to encourage people to donate something to another person. But in this study, we will test the effectiveness of two levels of implementation strategies based on upstream reciprocity to motivate gift recipients to get tested for gonorrhea. Specifically, we will compare a standard pay-IT-forward implementation strategy with minimal encouragement to get tested and a community-engaged pay-IT-forward strategy alongside a control arm in which men pay for their own STD test. Our pilot randomized controlled trial in two cities found that pay-IT-forward substantially increased gonorrhea testing compared to the control arm (56% in the pay-IT-forward arm, 18% in control arm). Our pilot data also suggests that greater MSM community engagement (e.g., MSM participatory activities to create testing messages) increases donations to the program, reinforcing the hypothesis that a community-engaged implementation strategy can activate upstream reciprocity. Intensified testing could also decrease antibiotic resistance. Building on our UNC project-china research infrastructure in china, we propose the pay-IT-forward gonorrhea testing RCT (pioneer). The study has the following specific aims: (1) to use a three-arm cluster randomized controlled trial to compare gonorrhea testing uptake in a standard pay-IT-forward strategy arm, a community-engaged pay-IT-forward strategy arm, and a control arm reflecting current practice; (2) to determine mechanisms through which different pay-IT-forward strategies activate upstream reciprocity to influence gonorrhea testing and donations; (3) to examine the impact of enhanced gonorrhea testing on the development of gonorrhea resistance. Based on our prior work, we hypothesize that a community-engaged pay-IT-forward strategy will increase gonorrhea test uptake rates compared to the standard strategy, and that pay-IT-forward in general is superior to the current practice of paid testing. Our proposal is innovative because IT provides a new financing mechanism to support gonorrhea testing, tests implementation strategies to enhance the effectiveness of this mechanism, and will provide more detailed information about the relationship between increasing testing and the development of antimicrobial resistance. This proposal has significant public health implications for the delivery of sexual minority health services in low and middle-income countries and is aligned with the mission of niaid.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $633,851 $0
Amendment $633,851 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $62,772 $0
Amendment $62,772 $0
Amendment $564,955 $0
Amendment $564,955 $0
Amendment $564,955 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $608,924 $0
Amendment $608,924 $0
Amendment $608,924 $0
Amendment $608,924 $0
Amendment $606,296 $0
Amendment $606,296 $0
Amendment $638,835 $0
Original award $638,835 $638,835
Show all 23

Subawards

Subrecipient Amount Awarded
University Of Washington This subaward focuses on organizing dissemination and secondary analyses from the completed RCT called PIONEER. The University of Washington (UW) investigator… $120,219
Dermatology Hospital Of Southern Medical University This research project proposes three specific aims with the overarching goal of using novel methodologies such as comparing point-of-care gonorrhea test… $248,308
Childrens Hospital Medical Center The Cincinnati Children's Hospital (CCH) researcher will work with the research team to provide implementation science expertise and advice on the design of the… $212,615
Sesh Global LLC SESH Global has used crowdsourcing method to develop intervention packages for improving HIV testing, condom use, HBV and HCV testing services. This Project… $849,646

Quick answers

Who received award R01AI158826?

R01AI158826 was awarded to University Of North Carolina At Chapel Hill by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 19, 2021.

How much is award R01AI158826 worth?

$8,652,904 has been obligated on R01AI158826: $8,014,069 in federal funding and $638,835 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award